Alain Vicari

Dr Vicari co-founded Calypso Biotech in 2013. Prior to Calypso Biotech, he accumulated more than 15 years international experience in translational immunology and drug discovery at Merck Serono, Pfizer Vaccines, Coley Pharmaceutical Group and Schering-Plough.

Dr Vicari received a Doctor in Veterinary Medicine degree from the Ecole Nationale Vétérinaire de Lyon and a PhD in Immunology from the Université Claude Bernard, Lyon. He completed post-doctoral training at the DNAX Research Institute (Palo Alto, California).